IT Systems and Solution Architect – R&D | IT Systems and Solution Architect* – R&D
AiCuris Anti-infective Cures AG
Job Summary
As an IT Systems and Solution Architect in the R&D sector, you will serve as the primary architect for a unified digital landscape supporting life-saving biotech research. Your daily responsibilities involve designing and maintaining enterprise-wide IT architecture, ensuring seamless integration of scientific business applications such as LIMS, QMS, and RIM. You will act as a technical bridge between scientific stakeholders and external Managed Service Providers (MSPs), translating complex requirements into scalable technical specifications. A major focus of the role is maintaining compliance with global biotech standards, specifically GxP and Computer System Validation (CSV). This position is ideal for a strategic thinker who enjoys designing distributed systems and managing high-level vendor relationships. It offers a unique opportunity to work within a collaborative, innovation-awarded environment where your architectural decisions directly impact the development of therapies for immunocompromised patients. The role provides high levels of flexibility, professional development support, and the chance to work with cutting-edge SaaS platforms like Veeva Vault.
Required Skills
Education
University degree in Computer Science, Bioinformatics, or a similar field; MBA or professional certifications (e.g., TOGAF, Azure Solutions Architect) preferred.
Experience
- Professional experience in designing and implementing complex, distributed systems
- Proven track record of managing large-scale implementation projects
- Experience managing multiple Managed Service Providers (MSPs) and external vendors
- Deep professional understanding of the regulatory landscape in Life Sciences (GCP, GLP, GMP, FDA, EMA)
- Experience in technical leadership and stakeholder negotiation
Languages
Additional
- Knowledge of biotech-specific systems (RIM, QMS, LIMS, eTMF, Serialization) is required. Must be able to ensure compliance with global regulatory standards including 21 CFR Part 11.